UTHR
UNITED THERAPEUTICS Corp
Latest Form 4:Sale$4.9MbyROTHBLATT MARTINE A (Chairperson & CEO) · filed Aug 31, 2026
UNITED THERAPEUTICS Corp (UTHR) has 50 SEC Form 4 filings (500 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 31, 2026.
The most active filer is Chairperson & CEO ROTHBLATT MARTINE A with 40 filings. Insiders have net sold $212.7M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Martine A. Rothblatt
- Employees:1,400
- HQ:Silver Spring, MD, US
- IPO:1999-06-17
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$212.7M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$22.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chairperson & CEO | Sale | 9,500 | $4.9M | Aug 31 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Aug 28 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.9M | Aug 27 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.9M | Aug 26 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.9M | Aug 25 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.9M | Aug 24 | SEC ↗ | |
| EVP & GENERAL COUNSEL | Sale | 8,300 | $4.3M | Aug 21 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.9M | Aug 21 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Aug 20 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.9M | Aug 19 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.8M | Aug 18 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.7M | Aug 17 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.8M | Aug 14 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.9M | Aug 13 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Aug 12 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Aug 11 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Aug 10 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Aug 7 | SEC ↗ | |
| EVP & GENERAL COUNSEL | Sale | 8,300 | $4.3M | Aug 6 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.9M | Aug 6 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.9M | Aug 5 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.9M | Aug 4 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $4.9M | Aug 3 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Jul 31 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Jul 30 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Jul 28 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Jul 28 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Jul 27 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Jul 24 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Jul 23 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Jul 22 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Jul 21 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Jul 20 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Jul 17 | SEC ↗ | |
| EVP & GENERAL COUNSEL | Sale | 8,300 | $4.4M | Jul 16 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Jul 16 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.0M | Jul 15 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.1M | Jul 14 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jul 13 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.2M | Jul 10 | SEC ↗ | |
MALCOLM JANFirst in 4 months | Director | Sale | 325 | $179K | Jul 10 | SEC ↗ |
| Chairperson & CEO | Sale | 9,500 | $5.3M | Jul 9 | SEC ↗ | |
| Chairperson & CEO | Sale | 9,500 | $5.3M | Jul 8 | SEC ↗ | |
| Chairperson & CEO | Sale | 8,599 | $4.7M | Jul 7 | SEC ↗ |
Related companies
UNITED THERAPEUTICS Corp is in the Healthcare sector.